By using an antibody specific to c-Myc, c-Myc abundance was evaluated through IHC staining, and human CRC tissues were divided into c-Myc+ and c-Myc++ groups accordingly (Figure 8A). This evidence concerns the gene MYC and colorectal carcinoma.